NUS
NUS
NYSE · Consumer products

Nu Skin Enterprises Inc - A

$7.33
+0.14 (+1.95%)
As of Mar 24, 3:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.27B
Net Income
137.16M
Gross Margin
69.4%
Profit Margin
10.8%
Rev Growth
-12.6%
D/E Ratio
0.29
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 69.4% 69.4% 56.7% 56.7%
Operating Margin 16.3% 14.7% 9.3% 8.2%
Profit Margin 10.8% 10.3% 7.2% 8.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.27B 1.46B 239.11M 240.56M
Gross Profit 883.10M 1.01B 135.59M 136.41M
Operating Income 207.14M 213.35M 22.12M 19.66M
Net Income 137.16M 141.28M 17.26M 21.16M
Gross Margin 69.4% 69.4% 56.7% 56.7%
Operating Margin 16.3% 14.7% 9.3% 8.2%
Profit Margin 10.8% 10.3% 7.2% 8.8%
Rev Growth -12.6% -12.6% +7.9% +9.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 41.03M 41.03M 116.04M 131.43M
Total Equity 143.30M 143.30M 382.53M 420.07M
D/E Ratio 0.29 0.29 0.30 0.31
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 248.73M 270.42M 32.19M 32.46M
Free Cash Flow 8.63M 9.23M